Atlas Trials

Evaluate the Effect of Entrectinib on the Pharmacokinetics of Midazolam in Cancer Patients

Clinical trial NCT03330990 · COMPLETED

Trial details

NCT number
NCT03330990
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Solid Tumor
Start date
2017-11-14
Primary completion
2018-07-11
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.